ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,750.00
0.01%
S&P ASX All Technology
3,049.90
-0.57%
Brent Oil
83.325
1.14%
US Dollar vs AUD
1.51003
-0.33%
Bitcoin
62,689.07
2.02%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Newellis Inc (NUWE)

  7. Newellis Inc (NUWE) News

NUWE

Newellis (NUWE)

Newellis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NUWE
DateTimeSourceHeadlineSymbolCompany
09/05/202423:00GlobeNewswire Inc.Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration TherapyNASDAQ:NUWENewellis Inc
09/05/202407:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NUWENewellis Inc
09/05/202407:26Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:NUWENewellis Inc
07/05/202422:00GlobeNewswire Inc.Nuwellis, Inc. Announces First Quarter 2024 Financial ResultsNASDAQ:NUWENewellis Inc
02/05/202423:00GlobeNewswire Inc.Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT TechnologyNASDAQ:NUWENewellis Inc
01/05/202408:09GlobeNewswire Inc.Nuwellis Announces Closing of $2.7 Million Public OfferingNASDAQ:NUWENewellis Inc
01/05/202406:41GlobeNewswire Inc.Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:NUWENewellis Inc
26/04/202423:17GlobeNewswire Inc.Nuwellis Announces Pricing of $2.7 Million Public OfferingNASDAQ:NUWENewellis Inc
09/04/202423:00GlobeNewswire Inc.Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford HealthNASDAQ:NUWENewellis Inc
12/03/202408:08Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NUWENewellis Inc
08/03/202401:08GlobeNewswire Inc.Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics ConferenceNASDAQ:NUWENewellis Inc
07/03/202404:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
06/03/202400:00GlobeNewswire Inc.Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:NUWENewellis Inc
05/03/202422:05IH Market NewsU.S. Futures Dip, Crude Oil FluctuatesNASDAQ:NUWENewellis Inc
28/02/202401:00GlobeNewswire Inc.Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024NASDAQ:NUWENewellis Inc
22/02/202423:58GlobeNewswire Inc.Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™NASDAQ:NUWENewellis Inc
21/02/202409:06GlobeNewswire Inc.Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NUWENewellis Inc
21/02/202400:42GlobeNewswire Inc.Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics ConferenceNASDAQ:NUWENewellis Inc
09/02/202409:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NUWENewellis Inc
07/02/202401:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
07/02/202401:00GlobeNewswire Inc.New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid OverloadNASDAQ:NUWENewellis Inc
10/01/202409:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NUWENewellis Inc
09/01/202401:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
05/01/202408:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUWENewellis Inc
05/01/202407:05GlobeNewswire Inc.Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral CatheterNASDAQ:NUWENewellis Inc
14/12/202308:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
29/11/202300:00GlobeNewswire Inc.New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric PatientsNASDAQ:NUWENewellis Inc
15/11/202308:30GlobeNewswire Inc.Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NUWENewellis Inc
08/11/202302:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NUWENewellis Inc
08/11/202300:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
 Showing the most relevant articles for your search:NASDAQ:NUWE

Your Recent History

NYSE
VZ
Verizon Communications
FX
GBPAUD
Sterling vs AUD
NASDAQ
AAPL
Apple
ASX
AMP
AMP
CCOM
SILVER
SILVER
ASX
FMG
Fortescue
ASX
XFL
S&P ASX 50
ASX
RIO
Rio Tinto
ASX
WOW
Woolworths
COIN
BTCUSD
Bitcoin
FX
AUDJPY
AUD vs Yen
ASX
XAO
Australian SE All Ordina...
FX
AUDCAD
AUD vs CAD
ASX
QBE
QBE Insurance
ASX
NAB
National Australia Bank
FX
AUDUSD
AUD vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved